Expertise in
36
conditions

Dr. David Y. Josephson

Urology
8635 West 3rd Street, Suite 1W, 
Los Angeles, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
36
conditions
8635 West 3rd Street, Suite 1W, 
Los Angeles, CA 

Overview

David Josephson is a Urologist practicing medicine in Los Angeles, California.

Dr. Josephson is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Hydronephrosis, Lymphadenectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 4 clinical trials. Dr. Josephson is currently accepting new patients.

Specialties

Urology

Licenses

Urology in CA

Hospital Affiliations

Providence Cedars Sinai Tarzana Medical Center
Cedars-Sinai Medical Center
Hoag Memorial Hospital Presbyterian

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

8635 West 3rd Street, Suite 1W, Los Angeles, CA 90048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: June 27, 2025
Intervention Type: Drug
Study Drug: Paclitaxel
Study Phase: Phase 1/Phase 2
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 1/2 Study of Participants With Biochemical Recurrence of Prostate Cancer
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 1/2 Study of Participants With Biochemical Recurrence of Prostate Cancer
Enrollment Status: Completed
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: 64Cu-SAR-bisPSMA
Study Phase: Phase 1/Phase 2
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: VERU-111, Enzalutamide, Abiraterone, Darolutamide and Apalutamide
Study Phase: Phase 3
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer
Enrollment Status: Completed
Publish Date: June 14, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

12 Total Publications

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Journal: Journal of the National Cancer Institute
Published: March 05, 2026
Similar Doctors
Expertise in
40
conditions
Expertise in
40
conditions
Referral may be required

Office

1516 San Pablo St Ste 3500, 
Los Angeles, CA 
 (9.8 miles away)
323-865-3700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Siamak Daneshmand is a Urologist practicing medicine in Los Angeles, California. Dr. Daneshmand is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Testicular Cancer, Cystectomy, and Bladder Reconstruction.

Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Mihir Desai, MD

1441 Eastlake Ave Ste 7416, 
Los Angeles, CA 
 (6.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mihir Desai is a Urologist practicing medicine in Los Angeles, California. Dr. Desai is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Enlarged Prostate (BPH), Renal Cell Carcinoma (RCC), Aquablation, and Cystectomy. Dr. Desai is currently accepting new patients.

Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required

USC Norris Comprehensive Cancer Center And Hospital

1441 Eastlake Ave, 
Los Angeles, CA 
 (10.1 miles away)
323-865-3700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hooman Djaladat is a Urologist practicing medicine in Los Angeles, California. Dr. Djaladat is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

Frequently Asked Questions about Dr. David Y. Josephson

How do I make an appointment with Dr. David Y. Josephson?

You can book an appointment with Dr. David Y. Josephson by calling their office at 310-854-9898. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David Y. Josephson a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Y. Josephson is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David Y. Josephson specialize in?

While Dr. David Y. Josephson is a Urology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Hydronephrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. David Y. Josephson participate in research or clinical trials?

Yes. Dr. David Y. Josephson has published 12 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. David Y. Josephson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David Y. Josephson accept my insurance?

Dr. David Y. Josephson accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-854-9898 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Josephson's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 27 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile